CBM-C20.1 - Cellular Biomedicine
Cellular Biomedicine: Biotech Showcase 2016 (Cellular Biomedicine Group) - Jan 30, 2016 - Anticipated initiation of P1/2b trials in multiple indications in China in H1 2016; Anticipated initiation of multicenter trial in NHL in 2016 
Anticipated new P1/2 trial • Anticipated new trial Non-Hodgkin's Lymphoma • Oncology
http://www.cellbiomedgroup.com/investor-relations/presentations/
 
Jan 30, 2016
 
.
 
41e8b7c6-bd36-4d36-aed4-293a23c24bd1.jpg

21ca89a3-64b7-482b-8180-526c38519745.jpg